Medical Communications

In a drastic bid to “streamline business, invest in new medicines and drive”, Eli Lilly has announced major staff cuts …

Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …

A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. …

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …

  

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …